Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Stanford, California 94305


Purpose:

To evaluate the role of high dose therapy and autologous or allogeneic hematopoietic cell transplantation for the treatment of chronic lymphocytic leukemia.


Study summary:

To determine effectiveness of allogeneic transplantation in eradicating chronic lymphocytic leukemia.


Criteria:

Inclusion Criteria:- adequate organ function - normal bone marrow cytogenetics Exclusion Criteria:- active CNS disease - For autologous patients more than 30% bone marrow involvement


NCT ID:

NCT00186303


Primary Contact:

Principal Investigator
Robert S Negrin
Stanford University


Backup Contact:

N/A


Location Contact:

Stanford, California 94305
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.